Rankings
▼
Calendar
▼
COEP Q2 2020 Earnings Report — Coeptis Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Coeptis Therapeutics, Inc.
COEP
Q2 2020 Earnings
Reported June 29, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q2 2020
Q1 2020
Q2 2019
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$448
$0
—
—
—
EPS (Diluted)
$-0.00
$0.00
—
-22600.9%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$448
Other Expenses
$0
Operating Expenses
$448
Cost & Expenses
$448
OPERATING INCOME
-$448
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
-$2
INCOME BEFORE TAX
-$450
Income Tax Expense
$0
Net Income from Continuing Ops
-$450
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$450
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$450
D&A
$0
EBIT
-$448
EBITDA
-$448
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
← FY 2020
COEP Overview
Q3 2020 →